Skip to main content

elamipretide

Generic: ELAMIPRETIDE HYDROCHLORIDE·Brand: FORZINITY

elamipretide: 2 clinical trials tracked.

elamipretide evidence translation

What we can confirm

2 tracked trials

No verified listed company relationship

What it means

AI will separate confirmed drug evidence from unknown company context.

What to watch

Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected

Prepared research question

What is verified about elamipretide, and what remains unknown?

Run cited research

Traceable citations · Unknowns marked

Clinical Trial Registry Records (2)

Phase 3b/4, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Trial to Evaluate the Efficacy and Safety of Daily Subcutaneous Injections of Elamipretide in Patients With Genetically Confirmed Barth Syndrome

NCT07531251Registry updated 2026-05-06·Phase 4
Not yet recruiting

Primary endpoint: Primary Efficacy End Point

InterventionalRandomizedquadruple48 targetStarted 2026-06Completion 2029-112 sites · United Kingdom, United StatesStealth BioTherapeutics Inc.

ReNEW: A Phase 3, Double-Masked, Placebo-Controlled Clinical Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of Subcutaneous Injections of Elamipretide in Subjects Who Have Dry Age-Related Macular Degeneration (Dry AMD)

NCT06373731Registry updated 2026-05-20·Phase 3
Active, not recruiting

Primary endpoint: Week 48 Rate of change in the macular area of photoreceptor loss

InterventionalRandomizedquadruple313 targetStarted 2024-05Completion 2027-0950 sites · Czechia, Germany, Hungary, Italy…Stealth BioTherapeutics Inc.